Tazeen Ahmad
Stock Analyst at Bank of America Securities
(4.48)
# 1,114
Out of 4,966 analysts
1033
Total ratings
60.5%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Reiterated: Sell | $317 | $377.35 | -15.99% | 7 | Sep 8, 2026 | |
| PHVS Pharvaris | Reiterated: Hold | $38 → $44 | $38.02 | +15.73% | 21 | Sep 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgraded: Hold | $48 → $20 | $14.30 | +39.86% | 51 | Sep 3, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $200 | $177.28 | +12.82% | 6 | Sep 2, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $346 | $248.68 | +39.13% | 50 | Aug 31, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $306 → $304 | $263.52 | +15.36% | 73 | Aug 31, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $27 | $10.49 | +157.39% | 22 | Aug 20, 2026 | |
| DFTX Definium Therapeutics | Initiated Coverage: Buy | $75 | $38.89 | +92.85% | 1 | Aug 18, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,088 → $1,136 | $984.39 | +15.40% | 66 | Aug 17, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Sell | n/a | $5.29 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.00 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.14 | - | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.88 | - | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $8.87 | - | 17 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $16.86 | - | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.02 | - | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 | $66.06 | +45.32% | 52 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.94 | +103.05% | 23 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $22.62 | +50.31% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $605 → $672 | $515.44 | +30.37% | 27 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.45 | - | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $21.26 | +45.85% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $3.80 | -21.05% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 → $123 | $116.47 | +5.61% | 17 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 → $2.5 | $2.98 | -16.11% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $55.41 | +4.67% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 → $18 | $20.45 | -11.98% | 71 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $31 | $27.83 | +11.39% | 48 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $162 | $143.72 | +12.72% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 → $122 | $96.73 | +26.12% | 54 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $149 | $104.00 | +43.27% | 44 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $199 → $214 | $156.22 | +36.99% | 48 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $856 → $891 | $781.49 | +14.01% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $136 → $140 | $121.47 | +15.25% | 55 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.12 | +84.73% | 36 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $2.2 | $2.31 | -4.76% | 12 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.04 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $79 | $13.17 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $1 | $1.05 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $0.5 | $17.80 | n/a | 7 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $3.21 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $4.59 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $334.58 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $19.41 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $9 | $17.02 | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $8 | $0.5724 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $143.97 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $29.55 | n/a | 1 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $2.14 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $11.85 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 → $48 | $25.22 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $5.14 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $9.52 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $1.13 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $7.96 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $112.79 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $20.51 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $52.89 | n/a | 1 | Sep 19, 2014 |
Amgen
Sep 8, 2026
Reiterated: Sell
Price Target: $317
Current: $377.35
Upside: -15.99%
Pharvaris
Sep 8, 2026
Reiterated: Hold
Price Target: $38 → $44
Current: $38.02
Upside: +15.73%
Ultragenyx Pharmaceutical
Sep 3, 2026
Downgraded: Hold
Price Target: $48 → $20
Current: $14.30
Upside: +39.86%
Belite Bio
Sep 2, 2026
Reiterated: Buy
Price Target: $200
Current: $177.28
Upside: +12.82%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $346
Current: $248.68
Upside: +39.13%
Ascendis Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $306 → $304
Current: $263.52
Upside: +15.36%
Ocular Therapeutix
Aug 20, 2026
Reiterated: Buy
Price Target: $27
Current: $10.49
Upside: +157.39%
Definium Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $38.89
Upside: +92.85%
argenx SE
Aug 17, 2026
Reiterated: Buy
Price Target: $1,088 → $1,136
Current: $984.39
Upside: +15.40%
Aardvark Therapeutics
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $5.29
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.00
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.14
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.88
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $8.87
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $16.86
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.02
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $96
Current: $66.06
Upside: +45.32%
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $3.94
Upside: +103.05%
Aug 11, 2026
Reiterated: Buy
Price Target: $34
Current: $22.62
Upside: +50.31%
Aug 10, 2026
Reiterated: Buy
Price Target: $605 → $672
Current: $515.44
Upside: +30.37%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.45
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $21.26
Upside: +45.85%
Aug 7, 2026
Reiterated: Sell
Price Target: $3
Current: $3.80
Upside: -21.05%
Aug 7, 2026
Reiterated: Buy
Price Target: $125 → $123
Current: $116.47
Upside: +5.61%
Aug 7, 2026
Reiterated: Sell
Price Target: $3 → $2.5
Current: $2.98
Upside: -16.11%
Aug 7, 2026
Reiterated: Buy
Price Target: $58
Current: $55.41
Upside: +4.67%
Aug 6, 2026
Reiterated: Sell
Price Target: $19 → $18
Current: $20.45
Upside: -11.98%
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $31
Current: $27.83
Upside: +11.39%
Aug 5, 2026
Reiterated: Buy
Price Target: $162
Current: $143.72
Upside: +12.72%
Aug 4, 2026
Reiterated: Buy
Price Target: $125 → $122
Current: $96.73
Upside: +26.12%
Aug 4, 2026
Reiterated: Buy
Price Target: $149
Current: $104.00
Upside: +43.27%
Jul 30, 2026
Reiterated: Buy
Price Target: $199 → $214
Current: $156.22
Upside: +36.99%
Jul 30, 2026
Reiterated: Buy
Price Target: $856 → $891
Current: $781.49
Upside: +14.01%
Jul 28, 2026
Reiterated: Buy
Price Target: $136 → $140
Current: $121.47
Upside: +15.25%
Jul 15, 2026
Reiterated: Buy
Price Target: $15
Current: $8.12
Upside: +84.73%
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $2.31
Upside: -4.76%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $1.04
Upside: n/a
Sep 19, 2024
Reiterated: Buy
Price Target: $82 → $79
Current: $13.17
Upside: n/a
Oct 17, 2023
Reiterated: Sell
Price Target: $2 → $1
Current: $1.05
Upside: n/a
Aug 11, 2023
Downgraded: Sell
Price Target: $7 → $0.5
Current: $17.80
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $3.21
Upside: n/a
Mar 27, 2023
Reiterated: Sell
Price Target: $6
Current: $4.59
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $334.58
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $19.41
Upside: n/a
Apr 19, 2022
Reiterated: Sell
Price Target: $10 → $9
Current: $17.02
Upside: n/a
Jul 21, 2021
Reiterated: Buy
Price Target: $16 → $8
Current: $0.5724
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $143.97
Upside: n/a
Jun 3, 2019
Initiated Coverage: Hold
Price Target: $28
Current: $29.55
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $2.14
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $11.85
Upside: n/a
Oct 10, 2018
Reiterated: Hold
Price Target: $46 → $48
Current: $25.22
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $5.14
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $9.52
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $1.13
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $7.96
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $112.79
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $20.51
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $52.89
Upside: n/a